Ablatherm

EDAP TMS SA develops and markets Ablatherm(R), the most advanced and clinically proven choice for high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer.

unknown title 2011

Ablatherm HIFU is a minimally-invasive prostate cancer treatment. 5 patients treated with

WN.com - Articles related to Physicians in Qatar work on treatment of ovarian cancer 2010

Approved in Europe as a treatment for prostate cancer, Ablatherm-HIFU (High Intensity Focused Ultrasound) is currently undergoing evaluation in a multicenter U.S.

News 2010

Ablatherm-HIFU treatment is in clinical trials, but not FDA-approved or marketed in the United States.

News 2010

Ablatherm-HIFU is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment.

News 2010

Ablatherm HIFU is a minimally-invasive prostate cancer treatment. 5 patients treated with Ablatherm share their experience before, during and after treatment.

WN.com - Articles related to Physicians in Qatar work on treatment of ovarian cancer 2010

It offers Ablatherm, a HIFU-based device for the treatment of organ-confined prostate cancer.

TradingMarkets 2010

Approved in Europe as a treatment for prostate cancer, Ablatherm-HIFU (High Intensity Focused Ultrasound) is currently undergoing evaluation in a multicenter U.S.

News 2010

Ablatherm share their experience before, during and after treatment.

WN.com - Articles related to Physicians in Qatar work on treatment of ovarian cancer 2010

Approved in Europe as a treatment for prostate cancer, Ablatherm-HIFU (High Intensity Focused Ultrasound) is currently undergoing evaluation in a multicenter U.S.

News 2010